Despite evidence that genetic factors contribute to the duration of gestation and the risk of preterm birth, robust associations with genetic variants have not been identified. We used large data sets that included the gestational duration to determine possible genetic associations.
Genetic Associations with Gestation and Preterm Birth P reterm birth (defined as birth before 37 completed weeks of gestation) affects 9.6% of pregnancies in the United States 1 and more than 15 million pregnancies worldwide each year. It is the leading cause of death in neonates and children under the age of 5 years. 2, 3 The majority of preterm births arise by spontaneous, idiopathic onset of uterine contractions or rupture of fetal membranes. 4 A substantial body of evidence has shown genetic influence in the duration of gestation and the risk of preterm birth. 5 For example, twin and family studies suggest that 30 to 40% of the variation in birth timing and in the risk of preterm birth arises from genetic factors that largely but not exclusively reside in the maternal genome. [6] [7] [8] [9] [10] Preterm birth, and gestational duration in general, is a complicated phenotype that is affected by both maternal and fetal genomes. The definition of preterm birth as a dichotomous trait on the basis of a somewhat arbitrary cutoff of 37 weeks of gestation, rather than time of birth for a specified level of fetal maturity or as a continuous trait, limits the interpretation of data and reduces the statistical power to detect association. 11 Therefore, we tested for genetic associations with gestational duration (a quantitative trait) as well as preterm birth (a dichotomous trait). To date, individual genomewide association studies (see Glossary) of spontaneous preterm birth have included approximately 1000 case mothers or infants with control groups of similar size. No replicated loci with genomewide significance have been reported. [12] [13] [14] To overcome sample-size limitations, we conducted genomewide discovery in a large cohort of women of European ancestry and tested associations that were identified in the discovery set for replication in three Nordic data sets.
Me thods

Discovery Data Set
We performed a two-stage genomewide association study to discover and replicate genetic loci associated with gestational duration and the risk of preterm birth. Women in the discovery data set were participants in the research program of 23andMe, a personal genomics and biotechnology company. All the women provided written informed consent and answered surveys online according to a human-subjects protocol approved by Ethical and Independent Review Services (www . eandireview . com). Unrelated women of European ancestry who self-reported the gestational duration of their first live singleton birth were included in the analysis. Women with a medical indication for their preterm delivery were excluded; those who did not specify a medical indication were included to optimize sample size. Preterm-birth status was determined on the basis of dichotomization of gestational duration (preterm, <37 weeks; term, ≥37 weeks).
DNA extraction and genotyping were performed by the National Genetics Institute. We restricted analyses to 43,568 women with more than 97% European ancestry, as determined by means of an analysis of local ancestry. 15 Genotype 1000 Genomes Project: An international collaboration to produce an extensive public catalogue of human genetic variation. Phase 1 of the project described genomes of 1092 samples from 14 populations. The haplotypes that are inferred from the 1000 Genomes Project data (reference haplotypes) can be used to impute genotypes at sites not on the original SNP array.
Genomewide association study (GWAS):
An approach used in genetics research to look for associations between many (typically hundreds of thousands) specific genetic variations (most commonly, single-nucleotide polymorphisms [SNPs]) and particular diseases or traits.
Genomewide complex trait analysis (GCTA): A computational tool that was originally designed to estimate the proportion of phenotypic variance explained by genomewide or chromosomewide SNPs for complex traits, has many other functions to analyze the genetic architecture of complex traits.
GTEx:
The Genotype-Tissue Expression project collects and analyzes multiple human tissues from donors to assess correlations between genotype and tissue-specific levels of gene expression. If the expression levels of genes are treated as quantitative traits, variations in gene expression that are highly correlated with genetic variation can be identified as expression quantitative trait loci.
GWAS Catalog:
A quality controlled, manually curated, literature-derived collection of all published genomewide association studies assaying at least 100,000 SNPs and all SNP-trait associations with P values of less than 1.0×10 −5 . The GWAS Catalog is provided jointly by the National Human Genome Research Institute and the European Bioinformatics Institute.
Locus:
The specific chromosomal location of a gene or other DNA sequence of interest.
Phenotype variance:
The proportion of interindividual difference (variance) in a phenotypic trait usually combines the genotype variance with the environmental variance.
RNA sequencing: RNA sequencing uses next-generation sequencing to detect and quantify RNA in a biologic sample to measure transcript abundance.
Single-nucleotide polymorphism (SNP):
A single-nucleotide variation in a genetic sequence; a common form of variation in the human genome.
Transcript: An RNA sequence resulting from transcription of a DNA sequence (often a gene).
Glossary
T h e ne w e ngl a nd jou r na l o f m e dicine data were imputed against the reference haplotypes of phase 1 of the 1000 Genomes Project. 16 We used linear regression to test single-marker genetic associations with gestational duration and logistic regression to test such associations with preterm birth on the basis of imputed allelic dosage (i.e., the expected allele count, as reported by the imputation program). We included as covariates the maternal age and the top five principal components to account for residual population structure (i.e., the difference in allele frequencies between subpopulations).
We clustered single-nucleotide polymorphisms (SNPs) into association regions (or loci) by first identifying SNPs with an association of P<1.0×10 −4 and then grouping these SNPs into a region if they were adjacent to each other (<250 kb). The SNP with the smallest P value within each region was chosen as the index SNP. Regions with suggestive significance (P<1.0×10 −6 ) were tested in the replication stage.
Tests of Replication
To test for replication, we used data from 8643 mothers and 4090 infants collected from three Nordic birth studies, 17 in which samples from preterm births were enriched and samples from births that were post-term or close to the preterm-term boundary (37 to 38 weeks of gestation) were excluded (Table S1 and Fig. S2 in the Supplementary Appendix, available with the full text of this article at NEJM.org). Genotyping on samples from these studies was conducted with the use of various SNP arrays, as described previously. 17 Participants of non-European ancestry were identified and excluded with the use of principal components analysis. We performed genomewide imputation using the reference haplotypes extracted from phase 1 of the 1000 Genomes Project. 16 We tested single-marker genetic association in each replication data set using methods similar to those used in the discovery stage. We used the fixed-effects inverse-variance method to calculate the replication P values after adjustment for the genomic inflation factor (which is used to quantify the excess false positive rate) in a combined analysis of the three Nordic data sets. Among the SNPs that had an association with genomewide suggestive significance (P<1.0×10 −6 ) in the discovery stage or SNPs in close linkage disequilibrium (r 2 >0.80), those that showed significant association (and in the same direction) in tests of replication were regarded as statistical evidence of replication of a putative locus. The significance level of each locus was corrected by the effective number of independent SNPs 18 that were tested in the locus and the total number of loci that were tested in the replication data sets (Table S6 in the Supplementary Appendix). An association was considered to be replicated if the P value of the most strongly associated SNP was less than the threshold of significance and had a combined discovery and replication P value of less than 5.0×10 −8 . We also performed association tests on samples obtained from the 4090 infants and joint maternal-fetal genetic association analysis in 3184 mother-infant pairs from the three replication sets that met the inclusion criteria (see the section describing the replication methods in the Supplementary Appendix) to evaluate whether the observed associations were driven by variants in the maternal genome or by variants in the fetal genome.
Statistical Analysis
We used the GWAS Catalog, 19 a database of all published genomewide association studies that is produced by a collaboration between the National Human Genome Research Institute and the European Bioinformatics Institute, to check whether the SNPs that were associated with gestational duration or preterm birth have been associated with other traits previously. In addition, we used the GTEx 20 database, which stores information on genotype and tissue-specific gene-expression levels, to determine whether any of the implicated SNPs could influence tissue-specific gene expression. We examined whether multiple independent variants at a given locus influenced birth timing by means of an approximate conditional and joint analysis. 21 We estimated the fraction of phenotype variance that was explained by all common SNPs 22 by means of genomewide complex trait analysis (GCTA) 23 or sets of significant SNPs using a genetic-score approach. 24 A detailed description of these analyses is provided in the section describing other statistical and bioinformatics analyses in the Supplementary Appendix.
R esult s
Study Data Sets
In the discovery data set, of the 43,568 women who had been identified through 23andMe, 37,803 (86.8%) had delivered at term (37 to 42 weeks), Genetic Associations with Gestation and Preterm Birth 3331 (7.6%) before term (<37 weeks), and 2434 (5.6%) after term (>42 weeks) (Tables S1 and S2 and Fig. S1 in the Supplementary Appendix). Maternal age was strongly associated with gestational duration (P = 2.3×10 −41 ) ( Table S3 in the Supplementary Appendix). In the three Nordic birth studies, 17 the sex of the infant and maternal height were associated with gestational duration (Table S4 in the Supplementary Appendix).
Discovery-Stage Findings in Mothers
Single-marker association tests were performed across 15,635,593 SNPs (see the Methods section in the Supplementary Appendix). The summary statistical outcomes of the top 10,000 SNPs have been deposited in the GeneStation repository (www . genestation . org/ analysis/ gwas/ Zhang_2017/ discovery), and summary statistics of the complete data set are available on request from 23andMe. The corresponding author holds a copy of the summary statistical outcomes of the full set of SNPs. Test results were adjusted for genomic inflation factors (Fig. S3 in the Supplementary Appendix).
With respect to gestational duration, 12 loci were identified with an association of P<1.0×10 −6 , 4 of which had an association of P<5.0×10 Panel A shows the 12 loci that were associated with gestational duration with "suggestive significance" (P<1.0×10 −6 , in orange), 4 of which were associated with "genomewide significance" (P<5.0×10 −8 , in red). Panel B shows the 5 loci that had an association with preterm birth with suggestive significance (in orange), 2 of which had an association of genomewide significance (in red). The top 3 loci that were associated with gestational duration (EBF1, EEFSEC, and AGTR2) were also associated with preterm birth. The names of the 6 replicated loci are highlighted in bold. T h e ne w e ngl a nd jou r na l o f m e dicine Genetic Associations with Gestation and Preterm Birth 5 loci were identified with an association of P<1.0×10 −6 , 2 of which had an association of P<5.0×10 −8 (Fig. 1B) . Of these 17 loci, the top 3 that were associated with gestational duration (EBF1, EEFSEC, and AGTR2) were also associated with preterm birth, so altogether, 14 independent loci were selected for replication. In similar association tests in a subgroup of discovery participants who explicitly checked "spontaneous delivery" in the questionnaire, the results were similar to those obtained from the full discovery data sets (Table S7 in the Supplementary Appendix).
Tests of Replication
Among the candidate 14 loci, 6 were significantly replicated: EBF1, EEFSEC, and AGTR2, which were associated with both gestational duration and preterm birth, and WNT4, ADCY5, and RAP2C, which had significant association with gestational duration but not with preterm birth (Table 1, and Tables S8 and S9 in the Supplementary Appendix). In addition, showing marginal significance (P<0.05) were associations between the BOLA3 locus with gestational duration and associations between the TEKT3 and TGFB1 loci with preterm birth.
Annotation of Implicated SNPs
Within these replicated loci, there are SNPs that have been reported as being associated with other complex traits (Tables S6 and S10 in the Supplementary Appendix) . 19 Three SNPs (rs10934853, rs2999052, and rs2687729) at the EEFSEC locus were associated with both gestational duration and preterm birth (Tables S8 and S9 in the Supplementary Appendix). The alleles that were associated with a longer duration of gestation have also been associated with an increased risk of prostate cancer (rs10934853-A), 25 a reduced risk of hypospadias (rs2999052-C), 26 and a later age of menarche (rs2687729-G). 27, 28 At the WNT4 locus, five significant SNPs in close linkage disequilibrium that were associated with gestational duration had been previously found to be associated with endometriosis, 29 ovarian cancer, 30 and bone mineral density. 31 The WNT4 alleles that we observed to be associated with increased gestational duration have been previously identified as risk alleles for endometriosis, ovarian cancer, and low bone mineral density (Table S10 in were tested for replication. For each region, the protein-encoding gene closest to the index SNP is shown. More details regarding all the discovery and replication loci are provided in Tables S5, S8 , and S9 in the Supplementary Appendix. † Alleles were determined on the basis of the positive strand of the reference genome. Allele B is used as the reference allele for frequency and effect. ‡ For gestational duration, the effect is the regression coefficient, which shows the estimated changes in the number of gestational days per B allele. A positive value indicates longer gestational duration. For preterm birth, the effect is the estimated odds ratio of the reference B allele. Odds ratios of more than 1 indicate an increased risk of preterm birth (i.e., a reduced gestational duration). § In the discovery stage, P values were adjusted by means of genomic inflation factors. In the replication stage, P values were calculated from the inflation-adjusted effect sizes and standard error of the three Nordic studies with the use of a fixed-effects meta-analysis. In the joint analysis, P values were calculated from the 23andMe and combined Nordic studies with the use of the inverse variance method.
¶ The r
T h e ne w e ngl a nd jou r na l o f m e dicine WNT4, and ADCY5) can influence the messenger RNA expression level of nearby genes 20 (Tables S11 and S12 in the Supplementary Appendix).
SNPs at the ADCY5 locus have been associated with birth weight 32 and blood glucose traits. 33 More recently, a meta-analysis has revealed SNPs at the ADCY5, WNT4, and EBF1 loci that are associated with birth weight. 34 The SNPs that were implicated in this meta-analysis, at the ADCY5 and WNT4 loci, appear to influence birth weight through the fetal genome. None of these SNPs were in close linkage disequilibrium with the SNPs showing significant association with gestational duration, whereas the SNP at the EBF1 locus (rs7729301) seems to influence birth weight through the maternal effect, and the allele (G) that was associated with reduced birth weight was associated with a shorter gestational duration (Tables S8 and S10 in the Supplementary Appendix).
Maternal or Fetal Genetic Effect?
We then tested for associations between the implicated SNPs and gestational duration and preterm birth in the infant samples (Tables S13 and S14 in the Supplementary Appendix). We observed the same associations as those in the maternal samples, and in the same direction, but with smaller effect sizes (Table S15 in the Supplementary Appendix). The effect sizes that were estimated from infant samples were highly correlated with the effect sizes that were estimated from the maternal samples (r 2 = 0.95) and were approximately half the size of those effects, a finding that supports the theory that the effect observed in infants is due to sharing of one maternal allele by descent (Fig. S4 in the Supplementary Appendix). In addition, joint association analysis in mother-infant pairs showed significant associations exclusively with maternal genotypes but not with fetal genotypes, which also indicates a maternal origin of the observed genetic associations (Table S16 in the Supplementary Appendix). The estimated phenotypic variances that were explained by all common SNPs in mothers (minor allele frequency, >0.01) were approximately 17% for gestational duration and 23% for preterm birth, as transformed to the heritability of the underlying disease liability (Table S18 in the Supplementary Appendix). Findings for detection of allelic heterogeneity, dominance effects, percentage of the variance explained, and gene set enrichment and pathway analyses are provided in the section describing other statistical and bioinformatics analyses in the Supplementary Appendix.
Functional Evidence Implicating WNT4
The WNT4 locus implicates the endometrium as a determinant of preterm birth. 35 The function of WNT4 is critical to decidualization of the endometrium and subsequent implantation and establishment of pregnancy. 36 Using RNA sequencing, we confirmed a substantial induction of WNT4 expression with decidualization, since we detected no transcripts per million before decidualization in vitro and 29.5 transcripts per million after decidualization.
We used the catalogue of inferred sequencebinding preferences 37 to predict transcription factors, the binding of which would be altered by the implicated variants at the WNT4 locus. We predicted that the thymidine (T) allele of rs3820282 (r 2 = 0.94 with the index SNP rs56318008) in the first intron of WNT4 would alter the binding of estrogen receptor 1 (ESR1). This allele creates a near-perfect half-site for ESR1 (Fig. 2A) . The derived enrichment score of the protein-binding microarrays, which evaluates the allele-specific binding strength, was 0.46 (indicating strong binding) for this allele, whereas that of the alternative allele, a cytosine (C) residue, was 0.09 (indicating no binding). This finding is consistent with the observation that ESR1 is capable of binding to this locus in a cellular context. 38 We confirmed the presence of H3K4me3 marks and an open chromatin domain overlapping rs3820282 in an immortalized endometrial stromal-cell line, which showed that the chromatin over this locus was probably accessible and active in these cells ( Fig. 2A) . (H3K4me3 is a histone modification that is found in active promoter regions, and an open chromatin domain indicates that the region is accessible to transcription factors.) Using an electrophoretic mobility shift assay, we detected enhanced binding of ESR1 to the T allele of rs3820282 (Fig. 2B) . Collectively, these data indicate that the association between gestational duration and the WNT4 locus is driven by the modulation of the binding of ESR1 through rs3820282.
Discussion
We identified and replicated six maternal genomic loci that were robustly associated with gestational Genetic Associations with Gestation and Preterm Birth duration and that contained genes in which the established functions are consistent with a role in the timing of birth. Three of these loci were also associated with preterm birth with genomewide significance.
EBF1, which encodes early B-cell factor 1, is essential for normal B-cell development, 39 and genomewide association studies have implicated it in the control of blood pressure, 40, 41 carotidartery intima-media thickness, 42 hypospadias, 26 and metabolic risk. 43 It remains to be determined whether EBF1 confers its effect on birth timing through pregnancy-specific mechanisms or by contributing to more general cardiovascular or metabolic traits that influence gestation. In addition, the association between this locus and gestational duration may explain the effect of this locus on birth weight, as reported by Horikoshi et al. 34 EEFSEC, which encodes selenocysteine tRNAspecific eukaryotic elongation factor, participates in the incorporation of selenocysteine into selenoproteins. Selenoproteins serve critical cellular homeostatic functions in maintaining redox status and antioxidant defenses, as well as modulating inflammatory responses. 44 These physiologic functions have been linked to the parturition pro- T h e ne w e ngl a nd jou r na l o f m e dicine cess and preterm birth. [45] [46] [47] Moreover, the SNPs we identified in EEFSEC are in high linkage disequilibrium with SNPs that have been associated with the risk of prostate cancer, 25 the risk of hypospadias, 26 and the age at menarche. 27 The identification of the selenocysteine pathway suggests a potential benefit for further evaluation of the role of maternal selenium micronutrient status on prematurity risk, as suggested by one study that showed an association between a reduced selenium concentration and preterm birth. 48 In addition, Malawi, the country with the highest global risk of preterm birth, 49 has a high prevalence of selenium deficiency. 50 It has been suggested that AGTR2, which encodes angiotensin II receptor type 2, plays a role in modulating uteroplacental circulation and harbors variants that may contribute to the risk of preeclampsia. 51, 52 It is unlikely that the association that we identified with AGTR2 indicates a risk of preeclampsia rather than of spontaneous preterm birth, because women with preeclampsia as a reason for their delivery were excluded from the Nordic studies and women were excluded from the 23andMe discovery data set if medical indications for delivery were reported.
WNT4, which encodes wingless-type MMTV integration site family member 4, was strongly replicated in the Nordic populations. WNT4 mutations have been found in women with müllerian duct abnormalities, primary amenorrhea, and hyperandrogenism, 53 and common variants in WNT4, which are in high linkage disequilibrium with our index SNPs, are associated with endometriosis, 29 ovarian cancer, 30 and bone mineral density. 31 Our analysis indicates that the T allele of the putative causative variant rs3820282 in the Nordic populations is associated with an increased gestational duration and is protective for preterm birth. The rs3820282 variant is located in an active chromatin domain in the first intron of WNT4, and the T allele generates a strong ESR1-binding site and as such probably alters the estrogen-based regulation of WNT4 or adjacent genes. The role of augmented estrogen signaling as the functional consequence of the polymorphism is further supported by the association of the same region with endometriosis and ovarian cancer, both of which are hormone-responsive disorders. Finally, the population prevalence of endometriosis among women of Asian, European, or African ancestry corresponds to the frequencies of the T allele of rs3820282 (0.49, 0.14, and 0.01, respectively). 54, 55 ADCY5, which encodes adenylyl cyclase type 5, and RAP2C, which encodes a member of the RAS oncogene family, had associations of nearly genomewide significance in the discovery stage and were successfully replicated (Table 1 ). SNPs at the ADCY5 locus have been reported to be associated with birth weight 32 and type 2 diabetes 33 ; however, none were in linkage disequilibrium with the SNPs showing significant association with gestational duration. The SNP rs2747022 in the RAP2C region (in gene FRMD7) was previously reported to be associated with spontaneous preterm delivery in Danish and Norwegian studies. 56 (The samples used in this study overlap with our replication samples.)
Our study had limitations regarding the characteristics of the discovery data set, in which data regarding gestational duration in the 23andMe samples were self-reported. One study has shown that approximately 90% of the gestational durations that were reported by mothers agreed with the associated medical records. 57 Also, we could not distinguish spontaneous births from medically indicated births among women who carried their pregnancies to term. In addition, all the participants in our study were of European ancestry, in both the discovery and replication data sets. Thus, whether the same loci are involved in birth timing among women of other ancestries is uncertain.
Our study shows the utility of combining large samples that have self-reported phenotyping with more modestly sized but precisely phenotyped replication studies to reveal maternal loci associated with gestational duration and preterm birth. With this foundation, we anticipate that larger studies of samples with maternal and fetal genotyping associated with data regarding gestational duration will further refine our understanding of human pregnancy and the risk of adverse pregnancy outcomes. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
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